Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Highest end of day price: $1953.60 USD on 2013-08-05
Lowest end of day price: $1.77 USD on 2023-09-22